SecBot SecBot

RPID

RAPID MICRO BIOSYSTEMS, INC.
Nasdaq· Laboratory Analytical Instruments· Inc. DE· CIK 0001380106 Industrials & Manufacturing
$0.7850 +0.01 (+0.64%)
Oct 26 4:00 PM ET · prev $0.7800
Market cap
$40.2M
Nano cap
Consensus
Buy
91% Buy or better · 11 analysts
Median target
$6.00
+664% · range $3.00–8.00
Next earnings
Nov 5
in 10 days · EPS est. −$0.20
1 year
−73.4%
from $2.95 · Oct 27
30 days
−28.3%
from $1.10
52-week range
$0.7640–4.68
−83% from high · low Oct 16
Avg volume 20D
204.6K
Oct 1 spike 523.5K
Short interest
854.0K
≈1.7% of shares · −9.2%
Days to cover
2.3
at average volume
Insider net
−$897.6K
1 buyer · 4 sellers · since Feb 2
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 5, 2026
Strongest BEARISH Rapid Micro Biosystems reported Q2 2026 revenue of $8.1M (+11% YoY), slightly above consensus of $7.9M, but…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $897.6K.

  • InstitutionsBEARISH

    Q2 2026: 1 added (0 new), 6 trimmed or exited.

  • AnalystsBULLISH

    10 of 11 rate it Buy or better. Every target is above the price.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.200 → −$0.203 over 90 days. 1 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −9.2% to 854.0K shares. 2.3 days to cover, ≈1.7% of shares.

  • TrendDOWNTREND

    32% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ADVENT INTERNATIONAL, L.P.TRIM379,794$657.0K
RENAISSANCE TECHNOLOGIES LLCADD212,101$366.9K
SEI INVESTMENTS CONEAR_EXIT66,869$115.7K
JANE STREET GROUP, LLCNEAR_EXIT25,931$44.9K
AMERICAN CENTURY COMPANIES INCTRIM11,638$20.1K
UBS Group AGTRIM6,607$11.4K
BARCLAYS PLCNEAR_EXIT337$583.00
SEI INVESTMENTS CODOUBLED284,816$646.5K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 91% rate it Buy or better
Strong Buy3Buy7Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +664%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 29, 2026Roth Capital
INITIATE
INITIATEBuy
May 29, 2026Keybanc
MAINTAIN
MAINTAINOverweight
May 22, 2026Lake Street
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 1 insider
$897.6K
sold · 4 insiders
DateInsiderTypeValue
Jul 24, 2026
Kollender Richard S
Director
EXERCISE$1.4K
Jul 24, 2026
Kollender Richard S
Director
EXERCISE$1.3K
Jul 22, 2026
Spignesi Robert G. Jr.
PRESIDENT AND CEO
EXERCISE$1.1K
May 29, 2026
Spignesi Robert G. Jr.
PRESIDENT AND CEO
AWARD$25.0K
May 29, 2026
Spignesi Robert G. Jr.
PRESIDENT AND CEO
AWARD12,787 sh
May 29, 2026
Spignesi Robert G. Jr.
PRESIDENT AND CEO
AWARD12,787 sh
May 29, 2026
WIRTJES SEAN M
CHIEF FINANCIAL OFFICER
AWARD$25.0K
May 29, 2026
WIRTJES SEAN M
CHIEF FINANCIAL OFFICER
AWARD12,787 sh

Earnings setup

Estimates
Nov 5
reports in 10 days
−$0.20
EPS estimate, this quarter
−1%
estimate change, 90 days
1↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.20-$0.21–-$0.19-1.3%$9.9M
Next Q-$0.16-$0.18–-$0.13-2.1%$13.3M
Current FY-$0.94-$0.96–-$0.91-0.6%$39.3M
Next FY-$0.71-$0.77–-$0.65+1.6%$46.3M

Short side

FINRA· Sep 30, 2026
853,972
shares short
-9.2%
vs prior settlement
2.3
days to cover
≈1.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 Other
Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the
Aug 7, 2026 SEC
Rapid Micro Biosystems reported Q2 2026 revenue of $8.1M (+11% YoY), slightly above consensus of $7.9M, but EPS of…
8-K — Impact 5/10
Jul 24, 2026 Insider
Kollender Richard S acquired via exercise 1,827 shares
Director @ $0.7500 ($1.4K)
Jul 24, 2026 Insider
Kollender Richard S acquired via exercise 1,681 shares
Director @ $0.7500 ($1.3K)
Jul 23, 2026 SEC
Rapid Micro Biosystems, Inc. announced it will report its Q2 2026 results on August 7, 2026.
PRESS-RELEASE — Impact 1/10
Jul 22, 2026 Insider
Spignesi Robert G. Jr. acquired via exercise 1,402 shares
PRESIDENT AND CEO @ $0.7500 ($1.1K)
Jun 30, 2026 Inst.
ADVENT INTERNATIONAL, L.P. — TRIM
379,794 shares ($657.0K)
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
212,101 shares ($366.9K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
RPID Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Oct 20, 2026
Press release
Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…
Aug 7, 2026
Earnings
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
LEXINGTON, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…
Aug 7, 2026
Earnings date
RPID Q2 2026 Earnings Scheduled — 2026-08-07
Jul 31, 2026
Earnings date
RPID Q2 2026 Earnings Scheduled — 2026-07-31
Jul 23, 2026
Earnings
Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026
LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…

SecBot reports

6 filings · 1 press release · 0 bullish · 3 bearish · 3 neutral
All RPID filing & press-release reports (7)